Top Markets
#1 EXOD EXOD +22.08%
#2 XPIN Network XPIN Network +21.92%
#3 Geodnet Geodnet +17.90%
#4 Neiro Neiro +17.59%
#5 Derive Derive +16.07%
#6 Mubarak Mubarak +15.58%
#7 Pons Pons +14.49%
#8 Collect on Fanable Collect on Fanable +13.17%
#9 Status Status +12.88%
#10 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +11.88%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Classificação em ações #25243
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Preço da ação
$23.57
Última sincronização: 2026-08-20
Valor de mercado
$51.76M
Variação (1 dia)
-0.08%
Variação (1 ano)
289.59%
País
US
Negociar Apollomics, Inc. (APLM)

Categoria

Healthcare
Lucros da Apollomics, Inc. (APLM)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Apollomics, Inc., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Apollomics, Inc. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US